Biotech entity
acquisition is the sole category represented across all 1 tracked stories. Hans Vorstenbosch is most often covered alongside Aspire Biopharma Holdings, Inc., which appears in 1 of these 1 story. Hans Vorstenbosch appears in 1 tracked Biotech story from August 11, 2026.
Last mentioned: Aug 11, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
acquisition is the sole category represented across all 1 tracked stories. Hans Vorstenbosch is most often covered alongside Aspire Biopharma Holdings, Inc., which appears in 1 of these 1 story. Hans Vorstenbosch appears in 1 tracked Biotech story from August 11, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 5 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Hans Vorstenbosch. Shared-story counts are live from our verified record — not editorial picks.
Aspire Biopharma, a Nasdaq-listed biotech, has closed the acquisition of Dura Driver Control Systems, a non-pharma automotive supplier. The $30 million all-cash deal brings over $200 million in annual revenue and $22.3 million in EBITDA, signaling a dramatic diversification away from pure drug development and into industrial cash flow generation.
Source: californiatelegraph.com · Dailyadvance
Hans Vorstenbosch is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
